JournalReviews in Cardiovascular Medicine
MetadataShow full item record
AbstractExtracorporeal life support (ECLS) was first implemented as an extension of cardiopulmonary bypass technology. The early use of ECLS in patients with acute respiratory distress syndrome (ARDS) was discouraging, likely due to limitations of technology and understanding of the disease process. However, over the last decade, there has been a rapid expansion in ECLS use. This ”rebirth” in 2009 was largely driven by the need for ECLS during the Influenza A subtype H1N1 pandemic and the results of the conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR) trial showing improved outcomes in patients with ARDS on ECLS compared to traditional management. Along with the increase in overall use of ECLS, there has been an increase in the number of patients with lung failure who are on long-term support, either awaiting lung recovery or transplantation. Many of these patients are awake, participating in physical rehabilitation, and even ambulating while supported with ECLS. Given the recent advances in patient care, and improvements in ECLS technology, the movement towards home for stable patients supported with ECLS may be on the horizon. Patients supported with ventricular assist devices (VAD) underwent a similar transition towards home in the 1990s, before which they were hospital bound. The road to an ambulatory home wearable lung will likely mirror that pathway. This review will give a brief overview of the transition of VAD patients out of the hospital, the history of ECLS, the current state of ECLS for lung failure, new and upcoming ECLS technology, and hurdles on the road home for ECLS patients.
KeywordAcute respiratory distress syndrome
End-stage lung disease
Extracorporeal life support
Extracorporeal membrane oxygenation
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/17609
- Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada.
- Authors: Freed DH, Henzler D, White CW, Fowler R, Zarychanski R, Hutchison J, Arora RC, Manji RA, Legare JF, Drews T, Veroukis S, Kesselman M, Guerguerian AM, Kumar A, Canadian Critical Care Trials Group.
- Issue date: 2010 Mar
- Use of extracorporeal life support to support patients with acute respiratory distress syndrome due to H1N1/2009 influenza and other respiratory infections.
- Authors: Wong I, Vuylsteke A
- Issue date: 2011 Jan
- Extracorporeal Life Support in Respiratory Failure.
- Authors: Short B, Burkart KM
- Issue date: 2022 Sep
- Extracorporeal life support in critically ill adults.
- Authors: Ventetuolo CE, Muratore CS
- Issue date: 2014 Sep 1
- Extracorporeal life support for severe acute respiratory distress syndrome in adults.
- Authors: Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ, Haft JW, Swaniker F, Arbabi S, Hirschl RB, Bartlett RH
- Issue date: 2004 Oct